Skye Bioscience, Common Stock Analysis

Skye Stock Analysis Notes

About 85.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.98. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Skye Bioscience, Common recorded a loss per share of 3.6. The entity had not issued any dividends in recent years. The firm had 1:250 split on the 8th of September 2023. Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. Skye Bioscience, Inc. was founded in 2012 and is headquartered in San Diego, California. Skye Bioscience operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 9 people. To find out more about Skye Bioscience, Common contact the company at 858 410 0266 or learn more at https://skyebioscience.com.

Skye Bioscience, Common Investment Alerts

Skye Largest EPS Surprises

View All Earnings Estimates

Skye Bioscience, Environmental, Social, and Governance (ESG) Scores

Skye Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 163.52 M.

Skye Profitablity

Management Efficiency

Skye Bioscience, Common has return on total asset (ROA) of (0.3039) % which means that it has lost $0.3039 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5482) %, meaning that it created substantial loss on money invested by shareholders. Skye Bioscience,'s management efficiency ratios could be used to measure how well Skye Bioscience, manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Equity is expected to grow to 18.54, whereas Return On Tangible Assets are forecasted to decline to (3.31). At present, Skye Bioscience,'s Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 12.2 M, whereas Total Assets are forecasted to decline to about 6 M.

Technical Drivers

As of the 29th of December, Skye Bioscience, has the Risk Adjusted Performance of (0.08), variance of 24.72, and Coefficient Of Variation of (872.30). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Skye Bioscience, Common, as well as the relationship between them. Please validate Skye Bioscience, Common market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Skye Bioscience, is priced more or less accurately, providing market reflects its prevalent price of 2.46 per share. Please also confirm Skye Bioscience, Common jensen alpha, which is currently at (0.59) to double-check the company can sustain itself at a future point.

Skye Bioscience, Common Price Movement Analysis

Skye Bioscience, Common Insider Trading Activities

Skye Bioscience, Outstanding Bonds

Skye Bioscience, Predictive Daily Indicators

Skye Bioscience, Corporate Filings

Skye Bioscience, Forecast Models

Skye Bioscience,'s time-series forecasting models are one of many Skye Bioscience,'s stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Skye Bioscience,'s historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Skye Bioscience, prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Skye shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Skye Bioscience,. By using and applying Skye Stock analysis, traders can create a robust methodology for identifying Skye entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Skye analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Skye analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Skye Bioscience, Common stock analysis indicators help investors evaluate how Skye Bioscience, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Skye Bioscience, shares will generate the highest return on investment. By understating and applying Skye Bioscience, stock analysis, traders can identify Skye Bioscience, position entry and exit signals to maximize returns.

When running Skye Bioscience,'s price analysis, check to measure Skye Bioscience,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Skye Bioscience, is operating at the current time. Most of Skye Bioscience,'s value examination focuses on studying past and present price action to predict the probability of Skye Bioscience,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Skye Bioscience,'s price. Additionally, you may evaluate how the addition of Skye Bioscience, to your portfolios can decrease your overall portfolio volatility.